Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 106276
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.106276
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.106276
Table 4 Tumor characteristics
| Characteristic | Infection group (n = 20) (%) | Non-infection group (n = 57) (%) | P value |
| Mean maximum tumor diameter (cm) | 6.8 ± 2.3 | 4.2 ± 1.9 | < 0.05 |
| Tumor diameter ≥ 5 cm | 40.3 (8/20) | 15.6 (9/57) | < 0.05 |
| Bilobar distribution | 55 (11/20) | 31.6 (18/57) | < 0.05 |
| Unilobar distribution | 45 (9/20) | 68.4 (39/57) | |
| Mean number of tumors | 2.1 ± 0.8 | 1.5 ± 0.6 | < 0.05 |
| Tumor location in right lobe | 30 (6/20) | 40.4 (23/57) | > 0.05 |
| Tumor location in left lobe | 25 (5/20) | 31.6 (18/57) | > 0.05 |
| Tumor location in both lobes | 45 (9/20) | 28.1 (16/57) | < 0.05 |
| Tumor grade (high grade) | 60 (12/20) | 40.4 (23/57) | < 0.05 |
| Tumor marker (CEA ≥ 5 ng/mL) | 50 (10/20) | 28.1 (16/57) | < 0.05 |
| Tumor marker (CA19-9 ≥ 37 U/mL) | 45 (9/20) | 24.6 (14/57) | < 0.05 |
| Tumor marker (AFP ≥ 20 ng/mL) | 35 (7/20) | 17.5 (10/57) | < 0.05 |
- Citation: Wang G, Qi R. Analysis of risk factors for post-operative infection following drug-eluting trans arterial chemo embolization in hepatocellular carcinoma: A retrospective study. World J Gastrointest Surg 2025; 17(6): 106276
- URL: https://www.wjgnet.com/1948-9366/full/v17/i6/106276.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.106276